13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • CVPM087A2101

    Acronym: 

    CVPM087A2101

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Bowel and colon, Kidney
    Trial Type Treatment
    Phase Phase I Tumour Stream Colorectal and gastroesophageal cancer Renal cell carcinoma
    Age Range 18 years and older Cancer Stage Metastatic or Widespread
    Sex Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Bowel and colon, Kidney
    Trial Type Treatment
    Phase Phase I
    Age Range 18 years and older
    Sex
    Molecular Target
    Tumour Stream Colorectal and gastroesophageal cancer Renal cell carcinoma
    Cancer Stage Metastatic or Widespread
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Phase Ib study of gevokizumab in combination with standard of care therapy in patients with metastatic colorectal cancer, gastroesophageal cancer and renal cell carcinoma

    Lay Summary

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    The Queen Elizabeth Hospital Pamela Cooper pamela.cooper@sa.gov.au 08 8222 6140 Professor Tim Price Recruiting